These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11951839)

  • 1. Tenofovir helps experienced patients.
    AIDS Patient Care STDS; 2002 Mar; 16(3):136. PubMed ID: 11951839
    [No Abstract]   [Full Text] [Related]  

  • 2. More uses for tenofovir?
    AIDS Treat News; 2001 Jan; (377):4. PubMed ID: 11862808
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of tenofovir.
    AIDS Patient Care STDS; 2002 Jan; 16(1):52. PubMed ID: 11892609
    [No Abstract]   [Full Text] [Related]  

  • 4. Promising results for tenofovir.
    AIDS Patient Care STDS; 2000 Jul; 14(7):396. PubMed ID: 10935058
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tenofovir (Viread)].
    Sidahora; 2002; (1):20-1. PubMed ID: 12772661
    [No Abstract]   [Full Text] [Related]  

  • 6. Tenofovir DF trial announced by Gilead.
    Eagan L
    Posit Living; 2000 Jul; 9(6):22, 54. PubMed ID: 12492018
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA approves tenofovir.
    AIDS Patient Care STDS; 2002 Jan; 16(1):52. PubMed ID: 11892608
    [No Abstract]   [Full Text] [Related]  

  • 8. Tenofovir: FDA hearing on important new antiretroviral.
    James JS
    AIDS Treat News; 2001 Oct; (372):2-4. PubMed ID: 11702411
    [No Abstract]   [Full Text] [Related]  

  • 9. Cambodia stops important tenofovir prevention trial.
    James JS
    AIDS Treat News; 2004 Jul; (403):4-5. PubMed ID: 15386853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenofovir drug interactions: ddI and d4T.
    TreatmentUpdate; 2003; 15(2):7. PubMed ID: 12693363
    [No Abstract]   [Full Text] [Related]  

  • 11. Tenofovir--long term results from first-line therapy.
    TreatmentUpdate; 2003; 15(2):4-6. PubMed ID: 12693361
    [No Abstract]   [Full Text] [Related]  

  • 12. Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication.
    van Bömmel F; Wünsche T; Schürmann D; Berg T
    Hepatology; 2002 Aug; 36(2):507-8. PubMed ID: 12143063
    [No Abstract]   [Full Text] [Related]  

  • 13. Tenofovir (Viread(R)) access for poor countries.
    James JS
    AIDS Treat News; 2002 Dec; (386):6-7. PubMed ID: 12569875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tenofovir in Study 903. Also effective and tolerable in first-line therapy].
    MMW Fortschr Med; 2002 Aug; 144(33-34):61. PubMed ID: 12380158
    [No Abstract]   [Full Text] [Related]  

  • 15. Tenofovir DF on the horizon. Investigational nucleotide reverse transcriptor inhibitor could be on pharmacy shelves soon.
    Eagan L
    Posit Living; 2001; 10(5):21. PubMed ID: 11693102
    [No Abstract]   [Full Text] [Related]  

  • 16. Tenofovir (viread) receives FDA approval.
    AIDS Alert; 2002 Jan; 17(1):10-1. PubMed ID: 11862732
    [No Abstract]   [Full Text] [Related]  

  • 17. Tenofovir approved: broad indication.
    James JS
    AIDS Treat News; 2001 Oct; (373):2-3. PubMed ID: 11768879
    [No Abstract]   [Full Text] [Related]  

  • 18. Tenofovir DF expanded access. Criteria for U.S. program.
    AIDS Treat News; 2001 Feb; (360):2-3. PubMed ID: 12173565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B infection in an HIV-positive man treated with tenofovir: a case of re-infection or reactivation?
    Richardson D; Lamba H
    Int J STD AIDS; 2004 Mar; 15(3):204-5. PubMed ID: 15038871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation.
    Van Bömmel F; Schernick A; Hopf U; Berg T
    Gastroenterology; 2003 Feb; 124(2):586-7. PubMed ID: 12557178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.